Mesoblast Ltd - ADR

NASDAQ:MESO 4:00:00 PM EDT

9.55

+0.79 (+9.02%)

: $10.20 +0.65 (+6.81%)

Market Cap (Intraday)	1.09B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$3.86 Million
Adjusted EPS	-$0.13

See more estimates

10-Day MA	$8.26
50-Day MA	$6.73
200-Day MA	$5.24

See more pivots

Mesoblast Ltd - ADR Stock, NASDAQ:MESO

55 Collins Street, Level 38, Melbourne, Victoria (VIC) 3000

Australia

Phone: +61.3.9639.6036

Number of Employees: 73

http://www.mesoblast.com

Description

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.